<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               17 PATIENT COUNSELING INFORMATION<BR>               <BR>                  <BR>                     See FDA-Approved Patient Labeling<BR>                  <BR>                  <BR>                     <BR>                        •<BR>                        Pregnancy<BR>                     <BR>                     <BR>                         Women of childbearing potential should be advised not to become pregnant while receiving FASLODEX. FASLODEX can cause fetal harm when administered to a pregnant woman [see Warnings and Precautions (5.3) and Use in Specific Populations (8.1)].<BR>                     <BR>                  <BR>                  <BR>                     <BR>                        •<BR>                        Blood Disorders<BR>                     <BR>                     <BR>                         Because FASLODEX is administered intramuscularly, it should be used with caution in patients with bleeding disorders, decreased platelet count, or in patients receiving anticoagulants (for example, warfarin) [see Warnings and Precautions (5.1)].<BR>                     <BR>                  <BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>